Top Markets
Coin of the day
Great Novel Therapeutics Biotech & Medicals Great Novel Therapeutics Biotech & Medicals

Great Novel Therapeutics Biotech & Medicals

7427
Rang in aandelen #20753
Great Novel Therapeutics Biotech & Medicals specializes in crafting... Great Novel Therapeutics Biotech & Medicals specializes in crafting pharmaceutical solutions to combat advanced and treatment-resistant cancers. Their primary focus lies in the realm of cancer immunotherapy, encompassing the creation of compounds such as tumor microenvironment regulators, epigenetic immunoactivators, and immune-regulating multi-kinase inhibitors. The company was previously known as GNT Biotech & Medicals Corporation. Established in 2013, its headquarters are situated in Taipei City, Taiwan.
Aandeelprijs
$2.33
Marktkapitalisatie
$122.59M
Verandering (1 dag)
0.41%
Verandering (1 jaar)
110.45%
Land
TW
Handel Great Novel Therapeutics Biotech & Medicals (7427)

Categorie

Dividendrendementgeschiedenis voor Great Novel Therapeutics Biotech & Medicals (7427)
Het dividendrendement (TTM) van Great Novel Therapeutics Biotech & Medicals (aandelsymbool: 7427) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Great Novel Therapeutics Biotech & Medicals (7427) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
0.00%
US
0.00%
NL
0.00%
US
3.12%
AU
0.00%
CH